Search clinical trials for: CS1 System

Total 80120 results

Cardiaccs AS
European Commission

Enrolling by invitation

Temporary Epicardial Pace Wire With Integrated Sensor for Continuous Postoperative Monitoring of Myocardial Function

Cardiac Disease | Myocardial Dysfunction

Norway
Cereno Scientific AB
Abbott; Worldwide Clinical Trials

Available

Safety and Efficacy of Continued CS1 Treatment of Patients With Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension

Sweden
National Cerebral and Cardiovascular Center
Juntendo University; Kyoto University; Kobe City General Hospital

Completed

Safety and Efficacy of Honeycomb Microporous Covered Stents (NCVC-CS1) for the Treatment of Intracranial Aneurysms (NCVC-CS1_UAN)

Intracranial Aneurysm

Japan
Zhejiang University
Yake Biotechnology Ltd.

Not yet recruiting

A Study of CS1-targeted CAR-T Cells Therapy for Relapsed Multiple Myeloma After BCMA CAR-T Cells Therapy

Relapse Multiple Myeloma

China
University of Maryland, Baltimore
CSA Medical, Inc.

Terminated

Study of Cryotherapy Treatment of Barrett's Esophagus and Early Esophageal Cancer

Esophageal Neoplasms | Deglutition Disorders | GERD | Barrett Esophagus | Neoplasm

United States
CardiacSense Ltd.

Completed

Performance and Efficacy of the CardiacSense1 for Detection of Atrial Fibrillation

Atrium; Fibrillation

Israel
Cereno Scientific AB
Worldwide Clinical Trials

Recruiting

Effect of CS1 in Subjects With Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension

Sweden
CSA Medical, Inc.

Terminated

Safety, Efficacy, and Side Effects Study of Interventional Cryotherapy in the Pleural Space("ICE PLS")

Cancer | Pleural Neoplasms

United States
Abbott Medical Devices
Clinical Accelerator

Completed

Cardiovascular Systems Inc. (CSI) pVAD First in Human Study

Coronary Artery Disease

Georgia
Abbott Medical Devices

Withdrawn

CSI Percutaneous Ventricular Assist Device (pVAD) Second in Human Study

Coronary Artery Disease

Georgia
Arga Medtech SA

Recruiting

Coherent Sine Burst (CSE) Electroporation System Pilot Study in Patients With Atrial Fibrillation (BURST-AF)

Atrial Fibrillation

Georgia
Mayo Clinic

Enrolling by invitation

Noninvasive Cochlear Stimulation System

Healthy

United States
Celyad Oncology SA
National Heart, Lung, and Blood Institute (NHLBI); Dana-Farber Cancer Institute

Completed

Safety Study of Chimeric Antigen Receptor Modified T-cells Targeting NKG2D-Ligands

Acute Myeloid Leukemia | Multiple Myeloma | Myelodysplastic Syndrome

United States
Rush University Medical Center

Enrolling by invitation

The Fluoroless-CSP Trial Using Electroanatomic Mapping

Heart Failure, Systolic | Sinus Node Dysfunction | Heart Block AV | LBBB

United States
iCell Gene Therapeutics
Peking University Shenzhen Hospital; iCAR Bio Therapeutics Ltd.; Chengdu Military...

Unknown

BCMA-CS1 Compound CAR (cCAR) T Cells for Relapsed/Refractory Multiple Myeloma

Multiple Myeloma

China
Catalyst OrthoScience

Recruiting

Catalyst CSR Shoulder System for Semi or Total Shoulder Arthroplasty

Osteoarthritis Shoulder | Avascular Necrosis of the Head of Humerus | Rheumatoid Arthritis Shoulder

United States
CSA Medical, Inc.

Terminated

CryoSpray Ablation(tm)in Malignant Airway Disease to Determine Safety, and Tissue Effect in the Lung (ICE the MAD) (ICEtheMAD)

Lung Cancer | Mesothelioma

United States
Changhai Hospital
Shanghai Zhongshan Hospital; Sixth Affiliated Hospital, Sun Yat-sen University and other collaborators

Completed

Adenoma Detection Rate Using AI System in China (SinoAIADR)

Colorectal Neoplasms | Adenoma | Colonic Polyp

China
University of Georgia
Cotton Incorporated

Recruiting

Cottonseed Oil Dose Response

Dyslipidemias | Overweight and Obesity | Nutrition, Healthy

United States
Abbott Medical Devices
ICON plc

Recruiting

Safety and Effectiveness Evaluation of Peripheral Orbital Atherectomy (KAIZEN)

Peripheral Artery Disease

Japan
Pfizer

Completed

Open Label Comparative Study Of De Novo Renal Allograft Recipients Receiving CSA + MMF + Corticosteroids Versus CSA + Rapamune + Corticosteroids

Inflammation

Iran, Islamic Republic of
University Hospital, Toulouse

Completed

Cerebrospinal Fluid Proteome in Hydrocephalus (PROLIPHYC)

Normal Pressure Hydrocephalus

France
Shire

Completed

A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE

Hereditary Angioedema

United States
CSL Behring

Terminated

Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients

Antibody-mediated Rejection

United States, Spain, France, Netherlands, United Kingdom, Belgium, Germany
Fundación Universitaria CIEO

Unknown

Er,Cr:YSGG Laser-aided Fiberotomy in the Prevention of the Lower Incisors Rotational Relapse (laser)

Rotated Teeth

Colombia
CSL Behring

Completed

A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema

Hereditary Angioedema Types I and II

United States, Spain, Germany, Australia, Canada, Czechia, Hungary, Israel, Italy, Romania, United Kingdom
IMMUNOe Research Centers

Completed

A Study to Evaluate the Benefit of RUCONEST® in Subjects Who Experience ADRs Related to IVIG Infusions

CVI - Common Variable Immunodeficiency

United States
Shire

Completed

A Pilot Study to Evaluate the Use of C1 Esterase Inhibitor (Human) in Patients With Acute Antibody-Mediated Rejection

Graft Rejection

United States, Germany
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

MDS (Myelodysplastic Syndrome) | Severe Aplastic Anemia

United States
Shire

Completed

Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks (CHANGE 3)

Hereditary Angioedema

United States
CSL Behring
Chiltern International Inc.

Completed

Patient Registry Study of Berinert® in Normal Clinical Practice

Includes: Hereditary Angioedema

United States, Denmark, Germany, Switzerland
Stanley Jordan, MD
CSL Behring

Completed

Safety & Tolerability of Berinert® (C1 Inhibitor) Therapy to Prevent Rejection

Kidney Transplantation

United States
CSL Behring

Completed

C1 Esterase Inhibitor in Hereditary Angioedema (HAE)(Extension Study)

Hereditary Angioedema

United States, Canada
Radboud University Medical Center

Completed

In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human Endotoxemia (VECTOR)

Inflammation | Endotoxemia | Multi Organ Dysfunction Syndrome

Netherlands
Shire

Completed

C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks

Hereditary Angioedema

United States
Shire

Completed

Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of Recombinant Human C1 Esterase Inhibitor in Healthy Adult Subjects

Hereditary Angioedema (HAE)

United States
Eximis Surgical

Terminated

Human Factors Actual-Use Clinical Protocol (CONTAIN)

Laparoscopic Gynecological Surgery

United States
Shire

Completed

Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks (CHANGE 2)

Hereditary Angioedema

United States
Shire

Completed

Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects

Hereditary Angioedema

United States
Michael Levy
ViroPharma

Completed

C1-esterase Inhibitor (Cinryze) for Acute Treatment of Neuromyelitis Optica Exacerbation

Neuromyelitis Optica

United States
CuraSen Therapeutics, Inc.

Completed

A Study of CST-2032 and CST-107 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's or Alzheimer's Disease

Dementia | Mild Cognitive Impairment

United States, New Zealand
CSL Behring
Parexel

Completed

A Study to Evaluate the Clinical Pharmacology and Safety of C1-esterase Inhibitor Administered by the Subcutaneous Route

Hereditary Angioedema Types I and II

United States, Germany
CuraSen Therapeutics, Inc.

Withdrawn

A Study of CST-2032 in Subjects With Cognitive Impairment

Mild Cognitive Impairment (MCI) | Parkinson Disease (PD)
NHS Greater Glasgow and Clyde
University of Glasgow

Terminated

Different Stimulation Patterns to Reduce Muscle Fatigue During FES

Spinal Cord Injuries

United Kingdom
Instituto de Mayores y Servicios Sociales (IMSERSO)
University of Castilla-La Mancha; Confederación Española de Alzheimer (CEAFA)

Active, not recruiting

Effectiveness and Cost-Effectiveness of Cognitive Stimulation Therapy - Spain (CST-ES) in People Living With Dementia

Neurocognitive Disorders | Dementia | Mild Cognitive Impairment

Spain
Haaglanden Medical Centre
Takeda; Leiden University Medical Center

Not yet recruiting

Complement Inhibition: Attacking the Overshooting Inflammation @Fter Subarachnoid Hemorrhage (CIAO@SAH) (CIAO@SAH)

Subarachnoid Hemorrhage, Aneurysmal
Cedars-Sinai Medical Center
OneLegacy Foundation

Active, not recruiting

Berinert (C1INH) vs Placebo for DGF/IRI

Chronic Kidney Diseases | End Stage Renal Disease

United States
Shire

Completed

C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks

Hereditary Angioedema

United States
Shire

Completed

Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1 Esterase Inhibitor for the Prevention of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema

Hereditary Angioedema (HAE)

Spain, Israel, United States, Hungary, Germany, Canada, Romania
Orasis Pharmaceuticals Ltd.

Completed

A Multi-Center, Double-Masked Evaluation of the Efficacy and Safety of CSF-1 in the Treatment of Presbyopia

Presbyopia

United States

Search clinical trials for: CS1 System

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Senegal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations